| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009970520 |
| P356 | DOI | 10.1038/GT.2010.152 |
| P698 | PubMed publication ID | 21107440 |
| P2093 | author name string | Z Lin | |
| T Wang | |||
| X Liu | |||
| Z Zhang | |||
| J Huang | |||
| C Chen | |||
| F Wang | |||
| X Cao | |||
| J Xiong | |||
| S Sun | |||
| Z Liang | |||
| M Jia | |||
| N Xiong | |||
| P2860 | cites work | Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells | Q44535345 |
| Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. | Q45879717 | ||
| Involvement of glyceraldehyde-3-phosphate dehydrogenase in rotenone-induced cell apoptosis: relevance to protein misfolding and aggregation. | Q46009959 | ||
| Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism | Q46650129 | ||
| VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model | Q47427098 | ||
| Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease | Q47659314 | ||
| Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. | Q47894301 | ||
| Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures | Q48203803 | ||
| Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease | Q48730943 | ||
| ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. | Q50738205 | ||
| The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993 | Q71775128 | ||
| Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord | Q78799982 | ||
| Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation | Q79901858 | ||
| Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke | Q80399919 | ||
| Specification of a dopaminergic phenotype from adult human mesenchymal stem cells | Q80683667 | ||
| Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation | Q82927480 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors | Q30160342 | ||
| Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord | Q30160386 | ||
| Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease | Q30895929 | ||
| Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease | Q33201042 | ||
| Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway | Q33415768 | ||
| From marrow to brain: expression of neuronal phenotypes in adult mice. | Q33926766 | ||
| Transplanted bone marrow generates new neurons in human brains | Q34330924 | ||
| Variation in the safety of induced pluripotent stem cell lines | Q34991636 | ||
| The potential role of vascular endothelial growth factor in the central nervous system | Q35939261 | ||
| HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia | Q36016430 | ||
| Pten, tumorigenesis, and stem cell self-renewal | Q36456220 | ||
| Concise review: therapeutic strategies for Parkinson disease based on the modulation of adult neurogenesis | Q36643351 | ||
| Demyelinating diseases and potential repair strategies | Q36780340 | ||
| Progress in Parkinson's disease-where do we stand? | Q37200943 | ||
| Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease | Q37221341 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia | Q37441879 | ||
| Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors | Q40118732 | ||
| Neurorescue effects of VEGF on a rat model of Parkinson's disease | Q40393076 | ||
| DNA polymerase-beta is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons | Q43236022 | ||
| VEGF 165 Expressed by a Replication-Deficient Recombinant Adenovirus Vector Induces Angiogenesis In Vivo | Q43580641 | ||
| Matrix cells from Wharton's jelly form neurons and glia | Q44279364 | ||
| P433 | issue | 4 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| human umbilical cord mesenchymal stem cell | Q107296600 | ||
| P304 | page(s) | 394-402 | |
| P577 | publication date | 2010-11-25 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease | |
| P478 | volume | 18 |
| Q26746033 | A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects |
| Q36861593 | Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease |
| Q26746977 | Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells |
| Q37931910 | An examination of regenerative medicine-based strategies for the urinary bladder |
| Q37635458 | Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo. |
| Q38068560 | Cell therapy: the final frontier for treatment of neurological diseases. |
| Q37949813 | Cerebrovascular disorders: molecular insights and therapeutic opportunities |
| Q104142348 | Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease |
| Q40228101 | Comparative Study on the Differentiation of Mesenchymal Stem Cells Between Fetal and Postnatal Rat Spinal Cord Niche |
| Q48583072 | Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease |
| Q35032638 | DNA-dependent protein kinase is a context dependent regulator of Lmx1a and midbrain specification |
| Q38715984 | Development of stem cell-based therapies for Parkinson's disease |
| Q43964216 | Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model |
| Q33763107 | Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum |
| Q27335848 | Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease |
| Q45277761 | Effects of storage solutions on the viability of human umbilical cord mesenchymal stem cells for transplantation |
| Q27308906 | Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats |
| Q36335166 | Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma |
| Q48258997 | Fibrin-based microsphere reservoirs for delivery of neurotrophic factors to the brain |
| Q33722420 | Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease |
| Q42470263 | Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT. |
| Q40049857 | In vitro induction and differentiation of umbilical cord mesenchymal stem cells into neuron-like cells by all-trans retinoic acid |
| Q38691269 | Induced pluripotent stem cells and Parkinson's disease: modelling and treatment |
| Q64767457 | Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases |
| Q38009051 | Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models |
| Q26747508 | Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives |
| Q92423873 | Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells |
| Q35864178 | Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy |
| Q38057859 | Parkinson's disease: from genetics to treatments |
| Q50598351 | Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice. |
| Q37041753 | Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells. |
| Q35224202 | Stem cell technology for neurodegenerative diseases. |
| Q39017141 | Stem cell therapies in age-related neurodegenerative diseases and stroke |
| Q55400539 | Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. |
| Q26862657 | Stem cells as drug delivery methods: application of stem cell secretome for regeneration |
| Q38133632 | Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system. |
| Q92394719 | Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases |
| Q36829006 | The effect of esculentoside A on lupus nephritis-prone BXSB mice |
| Q36710612 | The role of autophagy in Parkinson's disease: rotenone-based modeling |
| Q33771698 | The stem cell secretome and its role in brain repair |
| Q38867773 | Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. |
| Q37995017 | Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives |
| Q41429938 | Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons |
| Q38181179 | Use of umbilical cord and cord blood-derived stem cells for tissue repair and regeneration |
| Q47860045 | VEGF Signaling in Neurological Disorders |
| Q38882640 | Vascular endothelial growth factor: a neurovascular target in neurological diseases |
| Q37136467 | hVMAT2: A Target of Individualized Medication for Parkinson's Disease. |
Search more.